Adial Pharmaceuticals (ADIL) Cash from Discontinued Operations (2022 - 2023)
Adial Pharmaceuticals (ADIL) posted Cash from Discontinued Operations of 17585.0 for Q4 2023, up 92.18% sequentially from 225015.0 in Q2 2023, and up 94.92% YoY from 9021.46 in Q4 2022.
Adial Pharmaceuticals (ADIL) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Adial Pharmaceuticals has reported Cash from Discontinued Operations for 2 years, with the latest figure at 17585.0 in Q4 2023.
- Quarterly Cash from Discontinued Operations rose 94.92% year-over-year to 17585.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 1003441.0 (changed N/A YoY) and the FY2023 annual result came in at 1003441.0, up 61.29% from the prior year.
- Cash from Discontinued Operations climbed to 17585.0 in Q4 2023 per ADIL's latest filing, from 225015.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 17585.0 in Q4 2023 and troughed at 928092.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -17,585.00 |
| Dec 31, 2023 | -17,585.00 |
| Jun 30, 2023 | -225,015.00 |
| Jun 30, 2023 | -225,015.00 |
| Mar 31, 2023 | -760,841.00 |
| Mar 31, 2023 | -760,841.00 |
| Dec 31, 2022 | -346,439.00 |
| Dec 31, 2022 | -346,439.00 |
| Sep 30, 2022 | -928,092.00 |
| Sep 30, 2022 | -928,092.00 |